Structural and dynamical effects induced by the anticancer drug topotecan on the human topoisomerase I - DNA complex.
BACKGROUND: Human topoisomerase I catalyzes the relaxation of DNA supercoils in fundamental cell processes like transcription, replication and chromosomal segregation. It is the only target of the camptothecin family of anticancer drugs. Among these, topotecan has been used to treat lung and ovarian...
Main Authors: | Giordano Mancini, Ilda D'Annessa, Andrea Coletta, Nico Sanna, Giovanni Chillemi, Alessandro Desideri |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2010-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2880615?pdf=render |
Similar Items
-
Copper Complexes as Anticancer Agents Targeting Topoisomerases I and II
by: Caroline Molinaro, et al.
Published: (2020-10-01) -
The Lipophilic Purine Nucleoside—Tdp1 Inhibitor—Enhances DNA Damage Induced by Topotecan In Vitro and Potentiates the Antitumor Effect of Topotecan In Vivo
by: Irina A. Chernyshova, et al.
Published: (2022-12-01) -
Metronomic Chemotherapy Based on Topotecan or Topotecan and Cyclophosphamide Combination (CyTo) in Advanced, Pretreated Ovarian Cancer
by: Piotr J. Wysocki, et al.
Published: (2023-02-01) -
Natural Compounds as Therapeutic Agents: The Case of Human Topoisomerase IB
by: Alessio Ottaviani, et al.
Published: (2021-04-01) -
Enhanced Stability and Bioactivity of Natural Anticancer Topoisomerase I Inhibitors through Cyclodextrin Complexation
by: Víctor González-Ruiz, et al.
Published: (2021-10-01)